Education
About Us
Working with TipRanks
Follow Us
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -10.40K | $ -10.40K | $ -10.40K | $ -10.40K |
| Operating Income | $ -9.14B | $ -14.42M | $ -13.01M | $ -7.70M | $ -11.83M |
| EBITDA | $ -9.14B | $ -107.74M | $ -11.67M | $ -7.25M | $ -12.16M |
| Net Income | $ -9.41B | $ -98.30M | $ -759.10M | $ -8.91M | $ -13.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.53B | $ 3.14M | $ 5.90M | $ 328.58K | $ 174.67K |
| Total Assets | $ 20.60B | $ 22.11M | $ 118.51M | $ 1.13M | $ 685.57K |
| Total Debt | $ 0.00 | $ 8.66K | $ 108.76K | $ 9.15M | $ 3.82M |
| Net Debt | $ -1.53B | $ -3.13M | $ -5.79M | $ 8.82M | $ 3.64M |
| Total Liabilities | $ 12.08B | $ 11.04M | $ 18.51M | $ 13.63M | $ 9.24M |
| Stockholders' Equity | $ 8.52B | $ 11.07M | $ 99.99M | $ -12.50M | $ -8.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.56B | $ -8.72M | $ -1.49M | $ -5.08M | $ -5.11M |
| Operating Cash Flow | $ -7.56B | $ -8.72M | $ -1.49M | $ -5.08M | $ -5.11M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 5.95B | $ 5.96M | - | $ 5.23M | $ 4.56M |
ZyVersa Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.